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Abstract
Hsp90 is an essential chaperone that is necessary for the folding, stability and activity of numerous proteins. In this study,
we demonstrate that free radicals formed during oxidative stress conditions can cleave Hsp90. This cleavage occurs through
a Fenton reaction which requires the presence of redox-active iron. As a result of the cleavage, we observed a disruption of
the chaperoning function of Hsp90 and the degradation of its client proteins, for example, Bcr-Abl, RIP, c-Raf, NEMO and
hTert. Formation of Hsp90 protein radicals on exposure to oxidative stress was confirmed by immuno-spin trapping. Using
a proteomic analysis, we determined that the cleavage occurs in a conserved motif of the N-terminal nucleotide binding
site, between Ile-126 and Gly-127 in Hsp90b, and between Ile-131 and Gly-132 in Hsp90a. Given the importance of Hsp90 in
diverse biological functions, these findings shed new light on how oxidative stress can affect cellular homeostasis.
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Introduction
The 90 kDa heat shock protein (Hsp90) is a cellular
chaperone that is essential for the growth of eukaryotic cells
[1]. Hsp90 is one of the most abundant proteins in the
cytoplasm, where it exists as two closely-related isoforms: The
a isoform, which is highly inducible, and the b isoform, which
is constitutive. Hsp90 is divided into three main structural
domains: An N-terminal domain that binds ATP; a middle
domain that binds client proteins; and a C-terminal dimeriza-
tion domain that can also bind ATP [2]. The chaperone
function of Hsp90 depends on the availability of ATP. Indeed,
ATP binding to the N-terminal nucleotide-binding pocket and
its subsequent hydrolysis by Hsp90 drive a conformational cycle
that is essential for chaperone activity. However, considering
that the affinity of the Hsp90 N-terminal nucleotide-binding
pocket is greater for ADP than for ATP (Kd of 7.2 mM instead
of 240 mM), only a small modification of the ADP/ATP ratio
can affect Hsp90 function, changing the complex formed by
Hsp90 and other chaperones and co-chaperones into a form
that promotes client protein degradation by the ubiquitin-
proteasome pathway [2–5].
Interestingly, Hsp90 is constitutively expressed at 2–10-fold
higher levels in tumors compared to normal tissues [6]. Indeed,
Hsp90 is used by cancer cells to protect various mutated and
overexpressed oncoproteins (e.g., Bcr-Abl or mutated p53) from
misfolding and degradation [4,7]. Given its importance for the
growth and survival of tumor cells, Hsp90 has become an
attractive target for cancer therapy and many inhibitors have now
entered clinical trials. Several of these inhibitors carry a quinone
moiety and thus have redox-active properties. For instance, it has
been reported that ansamycin antibiotics, such as geldanamycin,
generate oxidative stress, which contribute to their cytotoxicity [8].
Since the precise role of oxidative stress in Hsp90 inhibition
remains unclear [9], we sought to determine the direct influence of
reactive oxygen species (ROS) generating systems on Hsp90
integrity. Indeed, it is well-known that ROS can oxidize proteins,
leading to damage such as the modification of amino acid side
chains, protein conversion to derivatives that are highly sensitive to
proteolytic degradation, and even cleavage of the polypeptide
chain [10].
In a previous report, we provided evidence that oxidative stress
can provoke the cleavage of Hsp90 in two leukemia cell lines
(K562 and KU812 cells) [11]. However, the precise mechanism
leading to this cleavage was unknown. Here, we demonstrate that
oxygen radicals, generated during the reaction between H2O2 and
an intracellular source of ionic iron chelated to adenine
nucleotides, attack and fragment the polypeptide backbone of
Hsp90, leading to the disruption of its chaperoning function and
the degradation of its client proteins.
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Results
Oxidative Stress Leads to Hsp90 Cleavage
In most of our experiments oxidative stress was generated
during ascorbate-driven menadione redox cycling, an ROS
generating system that has been extensively described by our
laboratory [12–14]. This system is initiated by electron transfer
from ascorbate (AscH2) to menadione (Q), as illustrated in
equation [1]:
AscH{zQ?SQ:{zAsc:{zHz 1½ 
SQ:{zO2?QzO2:{ 2½ 
Equation [2] shows the rapid reoxidation of the semiquinone
free radical (SQ.2) to its quinone form (Q) by molecular oxygen
leading to the formation of ROS derived from superoxide anion
(O2
.2), such as hydrogen peroxide (H2O2) or hydroxyl radicals
(HO.). After exposure of K562 cells to an oxidative stress
generated by A/M (2 mM/10 mM), we observed partial cleavage
of Hsp90 and a time-dependent formation of a C-terminal
fragment of about 70 kDa, as shown in Figure 1A. Interestingly,
neither a general lysosomal inhibitor (NH4Cl) [15], nor various
protease or proteasome inhibitors were able to inhibit the cleavage
induced by A/M, suggesting that the cleavage occurs through
a non-enzymatic mechanism (see Figure S1). Importantly, the
cleavage was not specific to A/M and similar results were obtained
with other H2O2-generating systems such as glucose/glucose
oxidase (Glox) (Figure 1B). Confirming the critical role of H2O2 in
this process, we observed that Hsp90 cleavage induced by A/M
was suppressed by addition of the antioxidant N-acetylcysteine
(NAC) or catalase to the incubation medium. We also observed
that deferoxamine (DFO), a potent cell-permeant iron chelator,
prevented the cleavage, suggesting involvement of a Fenton-type
reaction in the cleavage process (Figure 1B). Since iron can be
chelated by ADP [16], and given the presence of ATP/ADP
binding sites in Hsp90, we checked whether iron was carried by
nucleotides in the vicinity of the peptide backbone. For this
purpose, we used various Hsp90 inhibitors to block accessibility to
the nucleotide binding sites and to prevent an in situ Fenton
reaction. As shown in Figure 1B, geldanamycin (GA), 17-AAG,
and radicicol (Rd), which all bind to the N-terminal nucleotide
binding site of Hsp90 [7], suppressed the cleavage. Conversely,
novobiocin (NB), which binds to the C-terminal nucleotide-
binding pocket of Hsp90 [7], did not inhibit the Hsp90 cleavage
induced by A/M. In K562 cell lysates, Hsp90 cleavage by A/M
also required the presence of ionic iron and ADP (Figure 2A and
B, respectively). In this model, we also observed that blocking the
N-terminal nucleotide binding pocket with the specific inhibitors
described above led to the suppression of the cleavage (not shown).
Displacement of iron within the ADP-complex by adding
magnesium resulted in a progressive inhibition of Hsp90 cleavage
(Figure 2C). Hsp90 cleavage, with appearance of a major 70 kDa
C-terminal fragment, was also observed in cellular systems, cell
lysates, purified and recombinant Hsp90 proteins (Figure 1C).
2D-DIGE Analysis of K562 Cells after Oxidative Stress
Following two hours of A/M treatment, we detected three new
spots corresponding to a molecular size of about 70 kDa
(Figure 3A). Based on previous Western blots performed on 2D-
gels, these spots were identified as the 70 kDa C-terminal fragment
of cleaved Hsp90 (Figure S2). After preparative 2D gel electro-
phoresis, spots of interest were excised and submitted to in-gel
proteolytic digestion with either trypsin or chymotrypsin. Several
peptide fragments of either Hsp90 or its 70 kDa C-terminal
fragment were generated and analyzed by Electrospray Ultra-
High Resolution tandem TOF (UHR-Qq-TOF) (see Tables S1
and S2). The analysis of peptide fragments showed that Hsp90
isoforms a and b were both cleaved, but the comparative analysis
took into account the amino acid sequence of Hsp90b. Sequence
coverage analysis identified a region of 24 amino acids in which
the cleavage must have occurred. Indeed, the peptide
L138VAEKVVVITKHNDDEQY155, which was the most N-
terminal peptide to be identified in cleaved Hsp90b, was
immediately preceded by the peptide M114EALQAGADIS-
MIGQF129 in uncleaved Hsp90b, suggesting that the cleavage
site was located between Met-114 and Tyr-137 (Figure 3B).
Formation of Hsp90 Protein Radicals Following Oxidative
Stress
To gain further insight into the mechanism of Hsp90 cleavage,
we used the immuno-spin trapping technique for the detection of
putative Hsp90 protein radicals. This technique is based on
DMPO (5,5-dimethyl-1-pyrroline N-oxide), a spin trap agent,
which reacts with reactive radicals to form a stable adduct that can
be detected using immunoanalysis with anti-DMPO antibodies
[17]. Figure 4A and 4B show the rapid formation of a nitrone
adduct to both isoforms of Hsp90 (a and b) when the protein was
exposed to an oxidative stress. No adduct formation was observed
when Glox was omitted (Ctrl).
According to Stadtman et al [18,19], ROS-mediated oxidation
of proteins is a damaging process which can lead to cleavage of the
polypeptide chain. The mechanisms of peptide bond cleavage
following a-carbon oxidation are summarized in Figure 4C.
Briefly, the oxidative attack of the polypeptide backbone is
initiated by the HO.2dependent abstraction of the a-hydrogen
atom from an amino acid residue to form a carbon-centered
radical, which, in the presence of oxygen, is rapidly converted to
an alkylperoxyl radical (ROO.). Further reactions with HO2
., the
protonated form of superoxide anion (O2
.2), or transition metals
such as ferrous iron (Fe2+), lead to the formation of an alkoxyl
radical (RO.) which can undergo peptide bond cleavage by either
the a-amidation or diamide pathways [18,19]. As a consequence
of this mechanism, the N-terminal amino acid residue of the
fragment derived from the C-terminal portion of the protein may
exist either as an isocyanate (diamide pathway) or as an N-a-
ketoacyl derivative (a-amidation pathway).
Identification of the Cleavage Site
As predicted by the theoretical model presented in Figure 4C,
Edman sequencing was unsuccessful because of the absence of
a functional amine group at the N-terminal amino acid of the
70 kDa C-terminal fragment (not shown). As a consequence, we
decided to use mass spectrometry (UHR-Qq-TOF) to identify the
site of cleavage. We performed a total mass analysis of the two
main fragments that were observed after the cleavage of
recombinant Hsp90b by A/M (Figure 5A). The mass of the C-
terminal fragment of about 70 kDa could not be measured
precisely because it was too large to obtain a precise monoisotopic
profile. In contrast, the precise mass of the small N-terminal
fragment was successfully measured, giving a monoisotopic mass of
13777,1122 Daltons (Figure 5B). By using bioinformatic tools
(GPMAW 8.21 software), we found, with a precision of 5 ppm,
that such a mass corresponded to the theoretical mass of
a fragment peptide starting at Pro-2 and extending to Ile-126
(Figure 5C). We can, therefore, conclude that protein cleavage was
the result of a scission in the protein backbone between Ile-126
Oxidative Cleavage of Hsp90
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and Gly-127 in Hsp90b. It is noteworthy that hsp90a and b have
their initiator methionine removed, explaining that the N-terminal
fragment that we analyze begins with proline [20]. Only one other
peptide could correspond to the mass measured by mass
spectrometry but since it was an internal peptide (from Arg-82
to Gln-207), it was obvious that it could not be the N-terminal
fragment generated by the cleavage. Interestingly, the amino acid
sequence where the cleavage occurred (I126GQFGVGFYS135)
has previously been identified as a conserved motif in several
members of the Hsp90 family, and belongs to the N-terminal
nucleotide binding site of Hsp90 [21,22]. Finally, we noted that
Hsp90 cleavage is biologically relevant, as shown in Figure 5D.
Decrease in the abundance of various client proteins, including
Bcr-Abl, RIP, c-Raf, IKKc or hTert, is observed, reflecting a loss
of Hsp90 chaperone function which will ultimately provoke K562
cell death (not shown).
Discussion
This is the first study to show that ROS, formed by a Fenton-
type reaction in proximity to the N-terminal nucleotide binding
site of Hsp90, provoke oxidative cleavage of the polypeptide chain
of Hsp90. Indeed, other studies had previously shown that
chaperoning function of Hsp90 can be disrupted by protein
cleavage induced by hydrogen peroxide [23,24] or other reactive
oxygen species [25] but the mechanisms underlying such a protein
cleavage were unknown. In this study, the oxidative cleavage was
observed in intact cells, in cell lysates and with purified and
recombinant Hsp90 proteins, suggesting that proteases are un-
likely to be involved. Whatever the system used, the cleavage
yielded a similar C-terminal fragment of about 70 kDa. We
postulate that the mechanism of oxidative cleavage relies on local
generation of ROS in the Hsp90 N-terminal nucleotide-binding
pocket by interaction between ionic iron (chelated with adenine
nucleotides) and H2O2, generated either by ascorbate-driven
menadione redox cycling (A/M) or by the glucose/glucose oxidase
(Glox) system. Indeed, cleavage of H2O2 by iron (or copper) is
a major source of hydroxyl radicals under physiological conditions
[26].
In non-cellular systems (cell lysates, purified or recombinant
protein), the protein cleavage was ADP- and iron-dependent,
suggesting that ionic iron chelated with ADP was brought to the
nucleotide-binding site of Hsp90. Here, it reacted with H2O2
(generated by either A/M or Glox), leading to a local generation of
hydroxyl radical through a Fenton-type reaction. Interestingly,
a similar system (iron-ADP plus ascorbate) has been reported in
experiments performed to identify an N-terminal ATP-binding site
in purified Hsp90 proteins [27,28]. The need for iron in proximity
to the protein was confirmed by competition experiments with
magnesium salts (see Figure 2C). Indeed, Mg2+ can bind to ADP
Figure 1. Oxidative stress leads to Hsp90 cleavage and client protein degradation. (A) Time course of Hsp90 cleavage in K562 cells upon
treatment with A/M (2 mM/10 mM). Hsp90 was detected with an anti-C terminus antibody from Santa Cruz Biotechnology (Hsp90 a/b, clone F-8). (B)
Hsp90 cleavage in cells incubated for 2 hours with either A/M (2 mM/10 mM) or Glox (30 mM glucose/0.25 U/ml glucose oxidase), another H2O2-
generating system (top left). Suppression of Hsp90 cleavage in cells preincubated for 1 h with 3 mM N-acetylcysteine (NAC) or 100 U/ml of catalase
(CAT) and then exposed to A/M for 2 h (bottom left). Iron chelation by preincubating cells with deferoxamine (DFO) for 18 h decreased the cleavage
induced by 2 h treatment with A/M (top right). Preincubation of cells for 1 h with 10 mM of N-term Hsp90 inhibitors, like geldanamycin (GA), 17-AAG
(AAG) or radicicol (Rd), protected Hsp90 from the cleavage induced by 2 h treatment with A/M. Novobiocin (NB) at 1 mM did not protect (bottom
right). Hsp90 was detected with the same antibody as in (A). (C) Cellular Hsp90 cleavage was reproduced in K562 cell lysates, in purified Hsp90 from
HeLa cells, and in Hsp90 a and b recombinant proteins. K562 cells were incubated for two hours in the absence (Ctrl) or in the presence of A/M
(2 mM/10 mM). K562 cell lysates (100 mg) were incubated for 1 h in the absence (Ctrl) or in the presence of A/M supplemented with ADP (0.2 mM)
and FeCl3 (0.5 mM). For the experiments with purified and recombinant proteins, we used 2 mg of Hsp90, incubation lasted 30 min and A/M (2 mM/
10 mM) was supplemented with 0.2 mM ADP and 0.5 mM FeCl3. Note that Hsp90 was detected with the same antibody as in (A) with the exception of
recombinant Hsp90a that was detected with an anti-penta-His antibody.
doi:10.1371/journal.pone.0040795.g001
Oxidative Cleavage of Hsp90
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better than iron [29,30], so its addition displaces iron from the
ADP complex and, consequently, inhibits the generation of
hydroxyl radical and Hsp90 cleavage. These observations are in
agreement with the original description of a ‘‘site specific’’ Fenton
mechanism in which the binding of the transition metal ions to the
biological target is a prerequisite for the production of damage
[31].
In cellular systems, N-acetylcysteine and catalase prevented the
cleavage, indicating that oxidative stress, as a result of the
generation of H2O2, is required to cleave Hsp90. In intact cells, on
the contrary to non-cellular systems, any supplementation of either
iron or nucleotides was worthless. However, although the in-
tracellular source of iron was not identified, modulation of iron
availability by deferoxamine, an iron chelator, also prevented
Hsp90 cleavage, indicating that redox active iron is also required.
The need for adenine nucleotide bound to Hsp90 was further
confirmed by competition experiments with geldanamycin,
radicicol and 17-AAG, all well-known Hsp90 inhibitors [7]. By
binding to the N-terminal nucleotide-binding pocket of Hsp90,
these compounds prevented the binding of adenine nucleotides
(and therefore the putative ADP/iron complex) to the same pocket
and prevented Hsp90 cleavage. We can therefore conclude from
these observations that the presence of iron and nucleotides is
absolutely required for the cleavage, whatever the experimental
system used.
Further mass spectra analyses of the low molecular size
fragment obtained by oxidative cleavage of purified Hsp90
proteins allowed us to investigate the site of cleavage within the
protein. Since the precise mass of the N-cleaved fragment was
successfully measured as 13777.1122 Daltons, corresponding to
the molecular size of the peptide sequence from Pro-2 to Ile-126,
the site of cleavage in oxidized Hsp90b must be located between
Ile-126 and Gly-127, corresponding to Ile-131 and Gly-132 in
Hsp90a. Interestingly, the initial amino acid sequence of the C-
cleaved fragment of about 70 kDa starting at Gly-127, contains
the IGQFGVGFYS motif, except for Ile-126. It should be noted
that this motif (IGQFGVGFYS) has been reported as a conserved
sequence in Hsp90 proteins from different species [21,22], and
several papers have shown that it belongs to the nucleotide binding
site [21,32]. Moreover, Prodromou et al [21], working with
purified Hsp90 from Saccharomyces cerevisiae, reported that at
least the 3 glycines and the Phe-133 are actively involved in the
nucleotide binding pocket by interacting with phosphate groups
and Mg2+. The sequence coverage of digested peptides in the full
length protein and the cleaved fragment showed that the cleavage
took place within a region of 24 amino acids that contains the
IGQFGVGFYS motif. Interestingly, this motif did not contain
side-chains of amino acid residues that can be easily oxidized by
metal ion-catalyzed oxidation leading to peptide bond cleavage.
Indeed, the aromatic amino acids Phe-129, Phe-133 and Tyr-134
are preferential targets for oxidation to yield hydroxyl-derivatives,
while oxidation of Met-125, although not belonging to the amino
acid conserved sequence but close to Ile-126, may be considered as
part of a cyclic oxidation/reduction, and therefore a reversible
covalent modification [19]. Since HO. reacts with almost every
molecule at rate constants close to 109–1010 M216s21 [33], such
a lack of discrimination implies that a precise site of cleavage at
this particular region relies on both the in situ ROS formation and
the specific binding of the nucleotide that carries the metal-ion
catalyst. It can, therefore, be assumed that the site of cleavage in
K562 cells exposed to oxidative stress should be the same as that
observed with oxidized Hsp90b.
Pioneer work performed by Stadtman’s group has clearly
established that oxidation of proteins by ROS can lead to the
cleavage of peptide bonds either by a-amidation or diamide
pathways [10,19]. Based on the hypothetical scheme outlined in
Figure 4C, the N-terminal amino acid of the fragment derived
from the oxidative cleavage of the protein will exist either as an
isocyanate or an N-a-ketoacyl derivative, which explains the
unsuccessful assays to perform Edman sequencing for this 70 kDa
C-terminal fragment. Although this assumption needs further
investigation, it is likely that the C-terminal amino acid of the
fragment derived from the N-terminal region of the protein (i.e.
Ile-126) will exist as the amide derivative rather than a carboxylic
group, since the molecular mass determined by mass spectrometry
corresponds to within 0.01% to this condition. As discussed above,
prior to protein cleavage, formation of a protein radical is
required. The proposed mechanism of free radical attack involves
abstraction of a hydrogen atom leading to the formation of
a carbon-centered radical, which, in the presence of oxygen, is
rapidly converted to the peroxyl radical (Figure 4C). Immuno-spin
trapping analysis confirmed the formation of a protein radical
when Hsp90 was incubated with an H2O2-generating system. This
protein radical can be further rearranged, finally leading to protein
cleavage, presumably via the a-amidation pathway.
The biological relevance of Hsp90 cleavage by oxidative stress is
highlighted by the loss of its chaperone function, leading to client
protein degradation. Indeed, we report here and elsewhere [11,14]
the degradation of bcr-abl, RIP, Akt, mutated bcr-abl, c-Raf,
Figure 2. Hsp90 cleavage by A/M requires the presence of ionic
iron and ADP. K562 cell lysates (100 mg) were incubated for 1 h in the
absence (Ctrl) or in the presence of A/M (2 mM/10 mM) supplemented
with ADP (0.2 mM) and FeCl3 (0.5 mM). Different concentrations of ADP
(A), FeCl3 (B) and MgCl2 (C) were tested, as indicated. Hsp90 was
detected with an anti-C terminus antibody from Santa Cruz Bio-
technology (Hsp90 a/b, clone F-8).
doi:10.1371/journal.pone.0040795.g002
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hTert and IKKc/NEMO following the cleavage of Hsp90 by A/
M. Such a loss of chaperoning function is likely explained by the
removal of very important amino acid residues. Thus, Prodromou
et al [21] have identified, in yeast, that eleven amino acids of the
N-terminal domain participate in interactions with nucleotides,
namely Leu-34, Asn-37, Asp-40, Ala-41, Asp-79, Gly-83, Met-84,
Asn-92, Lys-98, Gly-118, Gly-121, Gly-123, Phe-124 and Thr-
171. These amino acids correspond to Leu-43, Asn-46, Asp-49,
Ala-50, Asp-88, Gly-92, Met-93, Asn-101, Lys-107, Gly-127, Gly-
130, Gly-132, Phe-133 and Thr-179 in human Hsp90b. Since the
cleavage of Hsp90b occurs between Ile-126 and Gly-127, it would
remove 9 of the 14 residues which are critical for nucleotide
binding. In addition, the cleavage would also remove Glu-42
(corresponding to Glu-33 in yeast), a catalytic glutamate residue
which is required for ATPase activity [21].
In conclusion, we have observed that in situ formation of ROS
by a Fenton-type reaction at the N-terminal nucleotide binding
pocket of Hsp90 forms a protein radical, which, by rearrangement,
causes the rupture of the peptide backbone and loss of its
chaperoning function. Interestingly, we have previously demon-
strated that oxidative cleavage of Hsp90 is preferentially observed
in cancer cells, where it leads to cell death, likely in response to the
destabilization and degradation of Hsp90 client proteins [11]. The
high sensitivity of cancer cells to the oxidative cleavage of Hsp90 is
probably explained by their general sensitivity towards oxidative
stress, a characteristic due to frequent alterations of their
antioxidant defenses and increased endogenous ROS production
[34–36]. Oxidative cleavage of Hsp90 could, therefore, be an
interesting option for killing cancer cells because this chaperone is
used by cancer cells to stabilize various mutated and overexpressed
oncoproteins that are critical for their growth and survival.
Materials and Methods
Cell Line and Chemicals
The K562 cell line (human chronic myelogenous leukaemia)
was purchased from ECACC (Salisbury, United Kingdom) and
maintained in RPMI medium supplemented with 10% fetal calf
serum, 100 mg/ml streptomycin and 100 U/ml penicillin. Men-
adione sodium bisulfite, sodium ascorbate, dimethylsulfoxide, D-
glucose, diethylenetriaminepentaacetic acid (DTPA), glucose
oxidase, hydrogen peroxide, FeCl3, novobiocin, deferoxamine
mesylate, catalase, protease inhibitor cocktail and radicicol were
purchased from Sigma (St Louis, MO, USA). Geldanamycin (GA)
and 17-allylamino-17-demethoxygeldanamycin (17-AAG) were
purchased from Invivogen (San Diego, CA, USA). ADP was
purchased from Roche (Basel, Switzerland). 5,5-Dimethyl-1-
pyrroline N-oxide (DMPO) was purchased from Enzo Life
Sciences (Farmingdale, NY, USA). Human recombinant Hsp90a
was prepared as follows: Briefly, the Hsp90a insert from pcDNA3-
Hsp90a plasmid (gift of Dr. Len Neckers, National Cancer
Institute, Rockville, MD, USA) was cloned into the bacterial
Figure 3. 2D-DIGE analysis of protein extracts from K562 cells exposed to oxidative stress. (A) K562 cells incubated for 2 h in the absence
(green) or the presence (red) of A/M (2 mM/10 mM). Spots corresponding to Hsp90 and its cleaved fragments were excised and analyzed by mass
spectrometry. (B) Peptides found after mass spectrometry analysis of the excised 2D-DIGE spots of cleaved and non-cleaved Hsp90 protein by either
tryptic (highlighted in green) or chymotryptic (underlined in red) peptides. Alignment was performed against the Hsp90b protein sequence.
doi:10.1371/journal.pone.0040795.g003
Figure 4. Formation of Hsp90 protein radicals following oxidative stress. (A) Immuno-spin trapping blots showing the formation of nitrone
adducts in Hsp90a (200 mg) incubated with DMPO (1 mM) and exposed to oxidative stress generated by Glox (60 mM glucose/1 U/ml glucose
oxidase) supplemented with ADP (0.2 mM) and FeCl3 (0.5 mM). Blank and Ctrl mean, respectively, that DMPO and Glox were omitted. (B) Same as (A)
but with Hsp90b. (C) Proposed mechanism leading to oxidative polypeptide cleavage according to Stadman et al [18,19].
doi:10.1371/journal.pone.0040795.g004
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expression vector pET28a. The construct was then transferred to
the E. coli BL21 and Hsp90a protein expression was induced by
the addition of 1 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG). Recombinant protein was then purified through an Ni-
NTA agarose column from Qiagen (Hilden, Germany). Human
Hsp90b recombinant protein and Hsp90 purified protein from
HeLa cells were purchased from Stressgen (Ann Harbor, MI,
USA). All other chemicals were ACS reagent grade.
Immunoblotting
Immunoblotting was performed as described previously [11].
Antibodies to c-Raf and c-abl were from Cell Signaling
Technology (Danvers, MA, USA), antibodies to hTERT, to
Hsp90 and to IKKc (NEMO) were from Santa Cruz Bio-
technology (Santa Cruz, CA, USA), antibodies to b-actin and
DMPO were from Abcam (Cambridge, UK), antibodies to RIP
were from Pharmingen (San Jose, CA, USA), and the penta-His
antibody was from Qiagen (Hilden, Germany).
2D-DIGE and MS Analysis
Cells were washed with PBS and lysed in a Tris buffer (30 mM,
pH 8.5) containing 7 M urea, 2 M thiourea, and 4% CHAPS.
Samples were centrifuged (13,000 g, 10 min) and supernatants
were kept at 280uC until use. Twenty-five micrograms of proteins
from four independent samples (2 controls and 2 treated) were
cross-labeled with 200 pmoles of Cy3 or Cy5 dyes. An equal
volume of buffer (7 M urea, 2 M thiourea, 2% CHAPS, 0.5% IGP
4–7 buffer and 0.4% DTT) was added to each sample. First-
dimension isoelectric focusing (IEF) was performed with 24-cm
Immobiline dry-strips, pH 4–7 (G.E. Healthcare, Uppsala,
Sweden). Strips were rehydrated according to the manufacturer’s
instructions and IEF was carried out on an IPGphor IEF system
(GE Healthcare), using a gradient increase in voltage (up to
8000 V) for a total of 50,000 Vh. Strips were equilibrated by two
steps of 15 min, first in 1.5 M TrisHCl, 6 M urea, 30% glycerol,
2% SDS, 1% DTT, and second in the same buffer with 2.5%
iodoacetamide but without DTT. SDS-PAGE was performed on
10% polyacrylamide gels. Gels were scanned with a Typhoon
9400 imager (GE Healthcare) and analyzed using DeCyder 2D
(GE Healthcare). Preparative 2-D gel electrophoresis was
performed using the same protocol, but with 200 mg of unlabeled
proteins. Gels were stained with Krypton (Pierce, Rockford, IL,
USA) and the spots of interest were excised by an automated
picker (GE Healthcare).
For mass spectrometric identification, proteins in gel were
digested overnight at 37uC with either trypsin or chymotrypsin
(Promega, Madison, IL, USA). Peptides were analyzed on a U-
3000 nanoLC (Dionex, Sunnyvale, CA, USA) equipped with an
Acclaim PepMap100 nano C18 column (Dionex) and coupled to
a Bruker maXis ESI Ultra-High Resolution tandem TOF (UHR-
Qq-TOF) mass spectrometer (nanoLC-MSMS). Peak lists were
created using Compass DataAnalysis 4.0 (Bruker, Bremen,
Germany) and imported in ProteinScape 2.0 (Bruker) using
a Mascot 2.2 (Matrix Science, London, UK) inhouse server.
Figure 5. Identification of the site of cleavage within Hsp90. (A) Silver stained SDS-PAGE gel showing both C-term and N-term protein
fragments of Hsp90b after 30 min incubation with A/M (2 mM/10 mM) supplemented with ADP (0.2 mM) and FeCl3 (0.5 mM). Asterisks show the
presence of contaminants. (B) Mass spectrometry analysis of cleaved Hsp90b. Deconvoluted spectra of the small N-term fragment gave a precise
monoisotopic mass of 13777.1122 daltons. (C) The picture illustrates the location of the cleavage site occurring in Hsp90b. The IGQFGVGFYS motif
corresponding to a conserved amino acid sequence in several Hsp90 proteins is highlighted in red. (D) Degradation of various Hsp90 client proteins
in K562 cells treated with A/M (2 mM/10 mM).
doi:10.1371/journal.pone.0040795.g005
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Enzyme specificity was set to trypsin or chymotrypsin and the
maximum number of missed cleavages was set at 1. Carbamido-
methylation and methionine oxidation were taken into account.
Protein identification was performed with the NCBInr database,
using a minimal individual peptide score equal or superior to the
identity score. The small fragment resulting from Hsp90 cleavage
was analyzed as described above, except that samples were
separated on an Acclaim PepMap300 C4 column. Mass spectra
were deconvoluted using Compass DataAnalysis 4.0 (Bruker) and
MaxEnt for charge deconvolution. GPMAW 8.2 (Lighthouse
Data, Odense, Denmark) was used to find the amino acid
sequence corresponding to the monoisotopic mass measured by
the maXis.
Supporting Information
Figure S1 Hsp90 cleavage is not suppressed by protease
inhibitors. K562 cells were preincubated for 1 h with the
following compounds: MG132 (40 mM), calpeptin (50 mM),
pepstatin (100 mM), antipain (50 mM), leupeptin (200 mM), and
NH4Cl (5 mM), and then further exposed to A/M (2 mM/
10 mM) for 2 h. Hsp90 was detected with an anti-C terminus
antibody from Santa Cruz Biotechnology (Hsp90 a/b, clone F-8).
(TIF)
Figure S2 Detection of cleaved and uncleaved Hsp90
after 2D gel electrophoresis. Cells were incubated for 2 h in
the absence (Ctrl) or in the presence of A/M (2 mM/10 mM).
Cells were lysed and samples were run on 2D gels, as described in
the Material and Methods section. Proteins were then transferred
to PVDF membranes and Hsp90 was detected with an anti-C
terminus antibody from Santa Cruz Biotechnology (Hsp90 a/b,
clone F-8).
(TIF)
Table S1 High-resolution UHR-Qq-TOF mass measure-
ments of peptides formed by the proteolytic digestion of
non-cleaved Hsp90.
(DOC)
Table S2 High-resolution UHR-Qq-TOF mass measure-
ments of peptides formed by the proteolytic digestion of
the 70 kDa C-terminal fragment of cleaved Hsp90.
(DOC)
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